Clinical Trial Update: ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury [NA]

View source ↗

Summary

This ongoing clinical trial is investigating ARC-IM Therapy for improving ambulatory function in people with subacute and chronic spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• ARC-IM Therapy

Snippet

Sponsor: Ecole Polytechnique Fédérale de Lausanne | Conditions: Spinal Cord Injury, SCI | NA | Status: RECRUITING